Androgens for genitourinary and vasomotor symptoms associated with menopause

Lucia A. Lara, Denisse Cartagena-Ramos, Debora Cantelli, Carla M.F. Dias, Sarah Armstrong, Vanessa Jordan, Miguel Fuentealba-Torres*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To evaluate the benefits and harms of androgens compared to placebo or no intervention, or another active treatment for genitourinary and vasomotor symptoms in perimenopausal or postmenopausal women.

Original languageEnglish
Article numberCD016052
JournalCochrane Database of Systematic Reviews
Volume2025
Issue number6
DOIs
StatePublished - 17 Jun 2025

Bibliographical note

Publisher Copyright:
Copyright © 2025 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The Cochrane Collaboration.

Fingerprint

Dive into the research topics of 'Androgens for genitourinary and vasomotor symptoms associated with menopause'. Together they form a unique fingerprint.

Cite this